XML 49 R13.htm IDEA: XBRL DOCUMENT v2.4.0.6
Goodwill and Other Acquisition-Related Intangible Assets
9 Months Ended
Sep. 29, 2012
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Other Acquisition-Related Intangibles
Goodwill and Other Acquisition-Related Intangible Assets
The Company is required to perform an impairment analysis on its goodwill at least annually, or when events and circumstances warrant. Conditions that would trigger an impairment assessment, include, but are not limited to, a significant adverse change in legal factors or in the business climate that could affect the value of an asset or an adverse action or assessment by a regulator. The Company is considered one reporting unit. As a result, to determine whether goodwill may be impaired, the Company first assesses qualitative factors to determine whether it is more likely than not that its fair value is less than its carrying amount as a basis for determining whether it is necessary to perform the two-step goodwill impairment test. If the two-step goodwill impairment test is necessary, the Company proceeds by comparing its book value to its market capitalization. If the trading price of the Company’s common stock, as adjusted for factors such as a control premium, is below the book value per share at the date of the annual impairment test or if the average trading price of the Company’s common stock is below book value per share for a sustained period, a goodwill impairment test will be performed by comparing book value to estimated market value. If the comparison of book value to estimated market value indicates impairment, then the Company compares the implied fair value of goodwill to its carrying amount in a manner similar to a purchase price allocation for a business combination. If the carrying amount of goodwill exceeds its implied fair value, an impairment loss is recognized equal to that excess.
Unless indicators warrant testing at an earlier date, the Company performs its annual goodwill impairment test in the fourth quarter of each year. During the nine months ended September 29, 2012, there were no impairments recorded or impairment indicators present.

Information regarding the Company’s acquisition-related intangible assets is as follows:
 
 
 
September 29, 2012
 
December 31, 2011
 
Useful
Life
(Years)
 
Gross Carrying Amount
 
Accumulated Amortization
 
Net Carrying Amount
 
Gross Carrying Amount
 
Accumulated Amortization

 
Net Carrying Amount
Goodwill
 
 
$
3,376

 
$

 
$
3,376

 
$
3,376

 
$

 
$
3,376

Amortizing intangible assets
 
 
 
 
 
 
 
 
 
 
 
 
 
In process research and development
3 - 5
 
1,779

 
(538
)
 
1,241

 
850

 
(270
)
 
580

Patents, trademarks and other
4 - 15
 
54,503

 
(32,967
)
 
21,536

 
49,653

 
(28,430
)
 
21,223

 
 
 
56,282

 
(33,505
)
 
22,777

 
50,503

 
(28,700
)
 
21,803

Non-amortizing intangible assets
 
 
 
 
 
 
 
 
 
 
 
 
 
In process research and development
 
 

 

 

 
929

 

 
929

Total intangible assets
 
 
56,282

 
(33,505
)
 
22,777

 
51,432

 
(28,700
)
 
22,732

Total goodwill and intangible assets
 
 
$
59,658

 
$
(33,505
)
 
$
26,153

 
$
54,808

 
$
(28,700
)
 
$
26,108


Amortization expense related to intangible assets is as follows:
 
 
Three Months Ended
 
Nine Months Ended
 
 
September 29,
2012
 
October 1,
2011
 
September 29,
2012
 
October 1,
2011
Amortization expense
 
$
1,649

 
$
1,548

 
$
4,805

 
$
4,556



The changes in the gross carrying amount of goodwill and intangible assets are as follows:
 
 
Goodwill and Intangible Assets
 
 
Goodwill
 
In process research and development- non-amortizing
 
In process research and development- amortizing
 
Patents, trademarks and other
 
Total
Balance as of December 31, 2011
 
$
3,376

 
$
929

 
$
850

 
$
49,653

 
$
54,808

Additions (deductions) during the period
 

 
(929
)
 
929

 
4,850

 
4,850

Balance as of September 29, 2012
 
$
3,376

 
$

 
$
1,779

 
$
54,503

 
$
59,658



During the nine months ended September 29, 2012 and October 1, 2011 product lines that were included in non-amortizing in process research and development ("IPR&D") reached technological feasibility. As a result, the Company transferred $929 and $250, respectively, to amortizing IPR&D and began amortizing these amounts over periods of five and three years, respectively.
The Company acquired developed technology for $4,850 during the nine months ended September 29, 2012 that will be amortized over a period of eleven years. The Company estimated the fair value of this asset using the relief from royalty valuation methodology discounted at a market discount rate. The Company did not have a similar acquisition during the nine months ended October 1, 2011.